This collaborative initiative brings together researchers from Massachusetts General Hospital, MIT, and Harvard University to advance the understanding of immune responses against infectious diseases like HIV/AIDS and tuberculosis. Its aim is to develop novel vaccines, diagnostics, and therapies through interdisciplinary research approaches.